Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been approved by the Food and Drug Administration for ...
The U.S. Food and Drug Administration said on Thursday there was no longer a shortage of Eli Lilly's blockbuster weight loss ...
The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...
The federal government is phasing out off-brand copies of two blockbuster drugs used to treat obesity and diabetes ...
The US Food and Drug Administration has finalized new standards that foods must meet before they can be labeled as “healthy.” ...
The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe ...
The U.S. Food and Drug Administration has approved Novo Nordisk's drug for the prevention or reduction of bleeding episodes ...
Packaged foods in the U.S. must follow new rules in order to call themselves “healthy.” That's according to changes finalized ...
The U.S. Food and Drug Administration reissued a decision first made by the agency in October that a shortage of the diabetes ...
Consumers who take copies of the weight loss drug Zepbound and diabetes drug Mounjaro will need to find a new source for ...
Eli Lilly said the FDA approved Zepbound for moderate-to-severe obstructive sleep apnea in adults with obesity, the first and ...
The Food and Drug Administration updated the definition of the claim “healthy” on food packaging, amid high incidences of ...